Prolonged oral MK-677 treatment significantly improved sleep quality in healthy young and older adults, increasing stage 4 (deep) sleep and REM sleep duration.
More deep sleep + more REMMK-677 increased both stage 4 (restorative) and REM sleep in young and older adults
What the researchers found
Prolonged oral MK-677 significantly improved sleep quality by increasing stage 4 (deep sleep) and REM sleep in both young (18-30) and older (65+) adults.
Why it matters
Sleep quality declines with age alongside GH secretion. A compound that improves both simultaneously could address two major age-related health concerns.
How the study worked
Double-blind study with 8 young (18-30) and 6 older (65+) subjects receiving oral MK-677 during treatment periods. Sleep was objectively measured by polysomnography.
What this study cannot tell us
Small sample sizes (8 young, 6 older). Double-blind but specific study duration and dosing not fully detailed in abstract. Long-term effects unknown.
How to read the evidence
Moderate clinical evidence with objective polysomnography measurements. Small sample sizes but consistent effects across age groups.
When this study was published
Published in 1997, this remains one of the most cited studies for MK-677's sleep benefits.
The bigger picture
This study revealed that MK-677's benefits extend beyond GH — improving sleep architecture is independently valuable for health, recovery, and cognitive function.
Questions still open
- Does improved sleep account for some of MK-677's body composition benefits?
- Is MK-677's sleep improvement maintained with long-term chronic use?
Common questions
How does MK-677 improve sleep?
Is this why people take MK-677 at bedtime?
Read the original research
Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man.
Neuroendocrinology, 66(4), 278-86
Citation
Copinschi, G; Leproult, R; Van Onderbergen, A; Caufriez, A; Cole, K Y; Schilling, L M; Mendel, C M; De Lepeleire, I; Bolognese, J A; Van Cauter, E. (1997). Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man.. Neuroendocrinology, 66(4), 278-86.